Clinical trial reportInfectious diseases and therapyPublished
A Phase 2 Trial Evaluating the Immunogenicity and Safety of an mRNA-Based Seasonal Influenza Vaccine Candidate Encoding Hemagglutinin and Neuraminidase
Regional connection
Verified An author affiliation on the Europe PMC record names GSK. Affiliation source
- Institution
- GSK
- County
- Montgomery County
Publication record
- Type
- Clinical trial report
- Venue
- Infectious diseases and therapy
- Published
- Topic
- Clinical care
- Subject terms
- Neuraminidase; Virus neutralization; Adverse Events; Hemagglutination Inhibition Assay; Neuraminidase Inhibition Assay; Mrna Vaccine; Next-generation Influenza Vaccine; Hemagglutinin, Influenza
- PubMed ID
- 42875682
- PubMed Central ID
- PMC13751912
- Open access
- Yes, open
- Added to directory
- Source checked